ATRA · Atara Biotherapeutics, Inc.
$7.90
-0.27 (-3.30%)
At close · Jul 24
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, we have concluded that substantial doubt exists with respect to our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”View the 10-Q filed May 12, 2026
Market Cap
$71.18M
Shares
9.01M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 1,000 | $11.17 | $11,170 |
| 2026-06-29 | 1,826 | $10.51 | $19,191 |
| 2026-06-26 | 7,404 | $10.22 | $75,669 |
| 2026-06-25 | 505 | $10.55 | $5,328 |
| 2026-06-23 | 1,147 | $10.61 | $12,170 |
| 2026-06-22 | 5,339 | $10.07 | $53,764 |
| 2026-06-18 | 6,788 | $9.67 | $65,640 |
| 2026-06-17 | 236 | $9.62 | $2,270 |
| 2026-06-16 | 1,142 | $9.96 | $11,374 |
| 2026-06-12 | 277 | $10.46 | $2,897 |
| 2026-06-11 | 344 | $9.86 | $3,392 |
| 2026-06-10 | 456 | $9.77 | $4,455 |
| 2026-06-09 | 612 | $9.58 | $5,863 |
| 2026-06-08 | 2,480 | $9.92 | $24,602 |
| 2026-06-02 | 1,438 | $10.28 | $14,783 |
| 2026-05-29 | 5,413 | $11.26 | $60,950 |
| 2026-05-28 | 18,459 | $10.54 | $194,558 |
| 2026-05-27 | 52 | $9.61 | $500 |
| 2026-05-26 | 177 | $9.80 | $1,735 |
| 2026-05-22 | 550 | $9.34 | $5,137 |
| 2026-05-21 | 11,499 | $9.45 | $108,666 |
| 2026-05-20 | 40,660 | $9.41 | $382,611 |
| 2026-05-19 | 32,677 | $9.15 | $298,995 |
| 2026-05-18 | 3,233 | $9.58 | $30,972 |
| 2026-05-14 | 16,635 | $10.48 | $174,335 |
| 2026-05-13 | 32 | $9.81 | $314 |
| 2026-05-12 | 15,119 | $8.78 | $132,745 |
| 2026-05-08 | 78,159 | $9.93 | $776,119 |
| 2026-05-07 | 200 | $5.15 | $1,030 |
Showing 1–29 of 29 settlements